Breaking News Instant updates and real-time market news.

AKAO

Achaogen

$8.34

0.04 (0.48%)

09:02
07/13/18
07/13
09:02
07/13/18
09:02

Achaogen 30% pullback since last month overdone, says William Blair

After attending the company's investor event, William Blair analyst Y. Katherine Xu says shares of Achaogen at current levels offer an attractive entry opportunity. While most of the Street has modeled the use of Zemdri in carbapenem-resistant enterobacteriaceae, extended-spectrum beta-lactamases-producing bacteria is also a major target and represents a much larger population, Xu tells investors in a research note. Further, she believes physicians are and will be comfortable to use Zemdri off-label in blood stream infections and pneumonia. The analyst views the 30% pullback in Achaogen shares since the complicated urinary tract infections approval last month as overdone and thinks her $23 fair value estimate could prove conservative. Xu keeps an Outperform rating on Achaogen.

AKAO Achaogen
$8.34

0.04 (0.48%)

05/03/18
HCWC
05/03/18
NO CHANGE
Target $19
HCWC
Buy
Achaogen price target lowered to $19 from $29 at H.C. Wainwright
H.C. Wainwright analyst Ed Arce lowered his price target for Achaogen to $19 after an FDA panel voted 11-4 against approval of plazomicin for the treatment of bloodstream infections. The analyst believes management may have to redo the calculus of optimizing the drug's market potential with perhaps a lower price than previously expected, but he still likes the shares at the $10-$11 range. He keeps a Buy rating on Achaogen.
05/04/18
RHCO
05/04/18
NO CHANGE
Target $16
RHCO
Buy
Achaogen price target lowered to $16 from $27 at SunTrust
SunTrust analyst Edward Nash lowered his price target on Achaogen to $16, citing yesterday's FDA Advisory Committee vote in favor of plazomicin in the treatment of complicated urinary tract infections but against the treatment of BSI. Nash says the negative outcome for this indication may not prevent its off-label use in BSI, keeping his Buy rating on Achaogen.
05/07/18
GUGG
05/07/18
DOWNGRADE
GUGG
Neutral
Achaogen downgraded to Neutral from Buy at Guggenheim
06/27/18
HCWC
06/27/18
NO CHANGE
Target $19
HCWC
Buy
Achaogen selloff following FDA approval excessive, says H.C. Wainwright
H.C. Wainwright analyst Ed Arce attributes the pullback in Achaogen shares after the company announced yesterday the FDA approval of Zemdri for cUTI to disappointment that the FDA did not also approve plazomicin for CRE infections via a bloodstream infections indication. However, while he believes a BSI indication would have been helpful, he thinks it is "by no means necessary" to successfully market Zemdri for CRE and he calls yesterday's selloff "excessive." Arce affirms a Buy rating on Achaogen shares with a $19 price target.

TODAY'S FREE FLY STORIES

AXSM

Axsome Therapeutics

$3.45

(0.00%)

09:42
10/17/18
10/17
09:42
10/17/18
09:42
Recommendations
Axsome Therapeutics analyst commentary  »

Axsome Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

MRCY

Mercury Systems

$51.48

(0.00%)

09:42
10/17/18
10/17
09:42
10/17/18
09:42
Periodicals
Breaking Periodicals news story on Mercury Systems »

Mercury Systems mentioned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

NUVA

NuVasive

$67.58

(0.00%)

09:41
10/17/18
10/17
09:41
10/17/18
09:41
Recommendations
NuVasive analyst commentary  »

NuVasive price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 27

    Nov

JNJ

Johnson & Johnson

$136.57

(0.00%)

09:41
10/17/18
10/17
09:41
10/17/18
09:41
Recommendations
Johnson & Johnson analyst commentary  »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 28

    Oct

XHB

SPDR Homebuilders

$35.63

(0.00%)

, KGC

Kinross Gold

$2.89

(0.00%)

09:40
10/17/18
10/17
09:40
10/17/18
09:40
Options
Unusually active option classes on open October 17th »

Unusual total active…

XHB

SPDR Homebuilders

$35.63

(0.00%)

KGC

Kinross Gold

$2.89

(0.00%)

SPOT

Spotify

$164.68

(0.00%)

NFLX

Netflix

$346.40

(0.00%)

LRCX

Lam Research

$145.33

(0.00%)

ATVI

Activision Blizzard

$78.73

(0.00%)

CGC

Canopy Growth

$52.96

(0.00%)

HD

Home Depot

$193.61

(0.00%)

AAL

American Airlines

$33.30

(0.00%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 01

    Nov

  • 08

    Nov

  • 13

    Nov

  • 14

    Nov

BLK

BlackRock

$408.00

-19.4 (-4.54%)

09:38
10/17/18
10/17
09:38
10/17/18
09:38
Recommendations
BlackRock analyst commentary  »

BlackRock price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

GS

Goldman Sachs

$221.76

6.48 (3.01%)

09:35
10/17/18
10/17
09:35
10/17/18
09:35
Recommendations
Goldman Sachs analyst commentary  »

Goldman Sachs price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

09:35
10/17/18
10/17
09:35
10/17/18
09:35
General news
IBM weighs on Dow as Netflix helps Nasdaq at outset »

Dow futures weakened…

WMT

Walmart

$95.83

1.98 (2.11%)

09:34
10/17/18
10/17
09:34
10/17/18
09:34
Recommendations
Walmart analyst commentary  »

Walmart analyst day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 15

    Nov

ABT

Abbott

$70.94

2.22 (3.23%)

09:33
10/17/18
10/17
09:33
10/17/18
09:33
Hot Stocks
Abbott says it sees great returns from Libre »

Says the street does not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

FLXN

Flexion

$19.62

1.17 (6.34%)

09:32
10/17/18
10/17
09:32
10/17/18
09:32
Periodicals
Flexion mentioned cautiously in a Seeking Alpha article 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

NFLX

Netflix

09:31
10/17/18
10/17
09:31
10/17/18
09:31
Recommendations
Netflix analyst commentary  »

Netflix growth story back…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

PII

Polaris Industries

$94.66

2.31 (2.50%)

09:31
10/17/18
10/17
09:31
10/17/18
09:31
Recommendations
Polaris Industries analyst commentary  »

Polaris Industries price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Dec

AA

Alcoa

$36.20

0.85 (2.40%)

09:31
10/17/18
10/17
09:31
10/17/18
09:31
Periodicals
Alcoa to close two aluminum plants in Spain, cut nearly 700 jobs, Reuters says »

Alcoa will two of its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

09:30
10/17/18
10/17
09:30
10/17/18
09:30
General news
The September housing report was disappointing »

The September housing…

NFLX

Netflix

09:28
10/17/18
10/17
09:28
10/17/18
09:28
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

TPR

Tapestry

$44.48

1.39 (3.23%)

09:27
10/17/18
10/17
09:27
10/17/18
09:27
Upgrade
Tapestry rating change  »

Tapestry upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

NFLX

Netflix

$346.40

13.29 (3.99%)

09:26
10/17/18
10/17
09:26
10/17/18
09:26
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

PVTL

Pivotal Software

$19.94

1.44 (7.78%)

09:25
10/17/18
10/17
09:25
10/17/18
09:25
Hot Stocks
Pivotal Software weakness attributed to lock-up expiration »

Shares of Pivotal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$158.81

5.25 (3.42%)

09:25
10/17/18
10/17
09:25
10/17/18
09:25
Periodicals
Facebook Watch lands The Real World from MTV, Deadline reports »

Facebook Watch will now…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 30

    Oct

  • 07

    Nov

COOP

Mr. Cooper

$15.22

-0.39 (-2.50%)

09:24
10/17/18
10/17
09:24
10/17/18
09:24
Recommendations
Mr. Cooper analyst commentary  »

Mr. Cooper price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSX

Diana Shipping

$3.95

0.07 (1.80%)

, GLNCY

Glencore

$0.00

(0.00%)

09:23
10/17/18
10/17
09:23
10/17/18
09:23
Hot Stocks
Diana Shipping reports continuation of time charter contract with Glencore »

Diana Shipping (DSX)…

DSX

Diana Shipping

$3.95

0.07 (1.80%)

GLNCY

Glencore

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEON

Neonode

$2.90

0.355 (13.95%)

09:23
10/17/18
10/17
09:23
10/17/18
09:23
Hot Stocks
Neonode regains compliance with Nasdaq minimum bid price requirement »

Neonode received a letter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KDMN

Kadmon

$2.89

0.195 (7.25%)

09:23
10/17/18
10/17
09:23
10/17/18
09:23
Hot Stocks
Kadmon announces FDA breakthrough therapy designation granted to KD025 »

Kadmon announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$145.02

3.9 (2.76%)

09:23
10/17/18
10/17
09:23
10/17/18
09:23
Recommendations
IBM analyst commentary  »

IBM price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.